Recent Study: EpiCast Report: Trigeminal Neuralgia - Epidemiology Forecast to 2022

Trigeminal neuralgia, also called tic douloureux, is a chronic nerve disorder characterized by severe facial nerve. The condition is more common in women compared with men and most commonly affects people ages 50 years and older. Globally the diagnosed incidence of trigeminal neuralgia varies between 4.3 cases per 100,000 person-years in Rochester, Minnesota, US, and approximately 28.9 cases per 100,000 person-years in the Netherlands. The total lifetime prevalence of trigeminal neuralgia in people ages 18-65 years ranged from 0.1% in Norway to 0.3% in Germany. Though the condition is not life-threatening, the pain associated can be debilitating, causing significant loss of quality of life and a decrease in activity levels.

GlobalData epidemiologists forecast that the diagnosed incident cases of trigeminal neuralgia in the 7MM will grow at 16.70% over the next decade, from 98,804 cases in 2012 to 115,275 cases in 2022. Comparably, GlobalData's epidemiological analysis forecasts that the total prevalent cases of trigeminal neuralgia in the 7MM will grow at 15.0% over the next decade, from the estimated 842,086 cases in 2012 to 968,360 cases in 2022.

Full Report Details at
- http://www.fastmr.com/prod/724863_epicast_report_trigeminal_neuralgia_epidemiology.aspx?afid=301

This increase in the number of incident and prevalent cases of trigeminal neuralgia in the 7MM can be attributed to changing population demographics in the respective markets rather than an actual forecast increase in the incidence and prevalence of trigeminal neuralgia.

Scope

* The trigeminal neuralgia EpiCast Report provides an overview of the risk factors and the global and historical trends for trigeminal neuralgia in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK and Japan). In addition, the report includes a 10-year epidemiological forecast (2012-2022) of diagnosed incident cases and total prevalent cases of trigeminal neuralgia segmented by age (ages 50-85+ years) and sex in these markets.
* The trigeminal neuralgia epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
* The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to Get this Report

* Develop business strategies by understanding the trends shaping and driving the global trigeminal neuralgia market.
* Quantify patient populations in the global trigeminal neuralgia market to improve product design, pricing, and launch plans.
* Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for trigeminal neuralgia therapeutics in each of the markets covered.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- EpiCast Report: Postherpetic Neuralgia - Epidemiology Forecast to 2022
- EpiCast Report: Overweight and Obesity - Epidemiology Forecast to 2022
- EpiCast Report: Diabetic Foot Ulcers - Epidemiology Forecast to 2022
- EpiCast Report: Hemophilia - Epidemiology Forecast to 2022
- EpiCast Report: Pediatric Respiratory Syncytial Virus Infection and Prophylactic Populations in the US - Epidemiology Forecast to 2022